Acute stroke and diabetes

Cerebrovascular Diseases

Volumn 20, Issue SUPPL. 1, 2005, Pages 9-14

  Lees, Kennedy R ^a   Walters, Matthew R ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Diabetes; Ischaemic stroke; Stroke outcome

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; CLOMETHIAZOLE; DESMOTEPLASE; FIBRINOLYTIC AGENT; GAVESTINEL; GLUCOSE; INSULIN; LUBELUZOLE; MAGNESIUM; POTASSIUM CHLORIDE; PROUROKINASE; STREPTOKINASE;

BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE UNIT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; STROKE; SYMPTOMATOLOGY;

ACUTE DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; RISK FACTORS;

EID: 27644588290     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088232     Document Type: Conference Paper

References (29)

1. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators: Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): Randomised controlled trial. Lancet 2004;363:439-445.
2. Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo JM, Whitehead J for the GAIN International Investigators: Glycine antagonist gavestinel in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. Lancet 2000;355:1949-1954.
3. Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, Koudstaal PJ, Wessel T on behalf of the LUB-INT-13 investigators: Lubeluzole in acute ischemic stroke treatment: a double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke 2000;31:2543-2551.
4. Lyden P, Shuaib A, Ng K, Levin K, Atkinson RP, Rajput A, Wechsler L, Ashwood T, Claesson L, Odergren T, Salazar-Grueso E, Hankey GJ: Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-1): Final results. Stroke 2002;33:122-129.
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
6. Hacke W, Kaste M, Fiescki C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-1251.
7. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, Hommel M, on behalf of the MAST-E Study Group: Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. Stroke 1999;30:1326-1332.
8. Weir C, Dyker AG, Lees KR: Is hyperglycaemia an independent predictor of poor outcome after stroke? Results of a long-term follow up study. BMJ 1997;314:1303-1306.
9. Christensen H, Boysen G: Blood glucose increases early after stroke onset: A study on serial measurements of blood glucose in acute stroke. Eur J Neurol 2002;9:297-301.
10. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001;32:2426-2432.
11. Aldasoro M, Martinez C: Influence of endothelial nitric oxide on adrenergic contractile responses of human cerebral arteries. J Cereb Blood Flow Metab 1996;16:623-628.
12. White RP, Deane C, Vallance P, Markus HS: Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke 1998;29:467-472.
13. Williams SB, Cusco JA: Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-574.
14. Tooke J, Goh K: Vascular function in Type 2 diabetes mellitus and pre-diabetes: The case for intrinsic endotheliopathy. Diabet Med 1999;16:710-715.
15. Caballero AE, Arora A: Microvascular and macrovascular reactivity is reduced in subjects at risk for Type 2 diabetes. Diabetes 1999;48:1858-1862.
16. Lehmann ED, Gosling R, Sonksen PH: Arterial wall compliance in diabetes. Diabet Med 1992;9:114-119.
17. Wilkinson IB, McCallum H: Increased augmentation index and systolic stress in Type 1 diabetes mellitus. Q J Med 2000;93:441-448.
18. Nazir F, Alem M, Walters MR, Cleland S, Lees KR: Cerebral nitric oxide-mediated vasodilatation is impaired in diabetics. Stroke 2004;35:306. Abstract P277.
19. Dietrich WD, Alonso O, Busto R: Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 1993;24:111-116.
20. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE, for the NINDS rt-PA Stroke Study Group: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002;59:669-674.
21. Kase CS, Furlan AJ, Wechsler LR, Higashida RT, Rowley HA, Hart RG, Molinari GF, Frederick LS, Roberts HC, Gebel JM, Sila CA, Schulz GA, Roberts RS, Gent M, and the PRO-ACT II Investigators: Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke. Neurology 2001;57:1603-1610.
22. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S, for the DIAS Study Group: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
23. Royal College of Physicians: National Clinical Guidelines for Stroke, ed 2. Prepared by the Intercollegiate Stroke Working Party. London, Royal College of Physicians of London, 2004.
24. Toni D, Chamorro A, Kaste M, Lees K, Wahlgren NG, Hacke W, for the EUSI Executive Committee and the EUSI Writing Committee: Acute treatment of ischaemic stroke. Cerebrovasc Dis 2004;17(suppl 2):30-46.
25. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marier JR, Hademenos GJ: Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
26. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaars D, Ferdinande P, Lauwers P, Bouillon R: Insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
27. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS: Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: The Glucose Insulin in Stroke Trial (GIST). Stroke 1999;30:793-799.
28. Sawin CT: Action without benefit. The sliding scale of insulin use. Arch Intern Med 1997;157:489.
29. Walters MR, Lees K: Safety and tolerability of rigorous glycaemic control with sliding scale insulin infusion following acute ischemic stroke. Stroke 2000;31:2834-2835.